CRP and non-small cell lung carcinoma: Two studies recently demonstrated the prognostic power of early CRP kinetics, such as flare response, in metastatic renal cell carcinoma (mRCC) [8] and advanced non-small cell lung cancer (NSCLC) [9] as early as 4 weeks after ICI initiation.